{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-10379"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-10379","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Cytoplasmic Polyadenylation Element Binding Protein 2 Alternative Splicing Regulates HIF1α During Chronic Hypoxia","abstract":"Chronic pulmonary hypoxia commonly results in the sustained expression of HIF1 (hypoxia inducible factor 1), a heterodimeric transcription factor, that, if unrestrained, can result in dramatic vasculature remodeling, pulmonary arterial hypertension, and right-sided heart failure. Together, these pulmonary disorders cost approximately $100 billion annually to treat due to the limited therapeutic targets designed to inhibit HIF1 expression. In this study, we introduce a translational regulator of HIF1 expression, known as Cytosolic polyadenylation element binding proteins 2 (CPEB2). Our lab has previously demonstrated in cancer cells that alternatively spliced isoforms of CPEB2 regulate the translation of the HIF1 oxygen-dependent subunit, HIF1α, in opposing fashions: the CPEB2A isoform represses its translation, while the CPEB2B isoform activates its translation. Although it is well established that during hypoxia, HIF1α levels are initially upregulated due to a decrease in proteasomal degradation, we hypothesized that during prolonged, or chronic, hypoxia, the expression of HIF1α is maintained through a stress-induced translational mechanism, likely alongside a decrease in proteolytic activity meant to stabilize HIF1α protein. Here we have demonstrated that targeting the CPEB2B splice isoform inhibited the translation of nascent HIF1α protein during chronic hypoxia, but not during acute hypoxia exposure. Moreover, we characterized how CPEB2A and B expression impacts vasculature remodeling in a 3D angiogenic cell model. These findings provide evidence that this splicing event could act as a therapeutic target for treating chronic hypoxia-related pulmonary diseases and diseases that present with dysregulated HIF1 expression.","abstract_html":"Chronic pulmonary hypoxia commonly results in the sustained expression of HIF1 (hypoxia inducible factor 1), a heterodimeric transcription factor, that, if unrestrained, can result in dramatic vasculature remodeling, pulmonary arterial hypertension, and right-sided heart failure. Together, these pulmonary disorders cost approximately $100 billion annually to treat due to the limited therapeutic targets designed to inhibit HIF1 expression. In this study, we introduce a translational regulator of HIF1 expression, known as Cytosolic polyadenylation element binding proteins 2 (CPEB2). Our lab has previously demonstrated in cancer cells that alternatively spliced isoforms of CPEB2 regulate the translation of the HIF1 oxygen-dependent subunit, HIF1α, in opposing fashions: the CPEB2A isoform represses its translation, while the CPEB2B isoform activates its translation. Although it is well established that during hypoxia, HIF1α levels are initially upregulated due to a decrease in proteasomal degradation, we hypothesized that during prolonged, or chronic, hypoxia, the expression of HIF1α is maintained through a stress-induced translational mechanism, likely alongside a decrease in proteolytic activity meant to stabilize HIF1α protein. Here we have demonstrated that targeting the CPEB2B splice isoform inhibited the translation of nascent HIF1α protein during chronic hypoxia, but not during acute hypoxia exposure. Moreover, we characterized how CPEB2A and B expression impacts vasculature remodeling in a 3D angiogenic cell model. These findings provide evidence that this splicing event could act as a therapeutic target for treating chronic hypoxia-related pulmonary diseases and diseases that present with dysregulated HIF1 expression.","abstract_has_math":false,"creators":["Mayo, Emily M."],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Biology (Cell Biology, Microbiology, Molecular Biology)","degree_department":null,"school":null,"contributors":["Sandy Westerheide, Ph.D.","Margaret Park, Ph.D., M.S.","Marcus Cooke, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-06-24T07:00:00Z","date_published":"2021-06-24T07:00:00Z","updated_at":"2026-11-19T08:47:49Z","subjects":["CPEB2","translation","angiogenesis","hypoxic stress response","Cell Biology","Molecular Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/9182","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/9182","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-10379","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Sandy Westerheide, Ph.D.","Margaret Park, Ph.D., M.S.","Marcus Cooke, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Mayo, Emily M."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2021-06-24T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology (Cell Biology, Microbiology, Molecular Biology)"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["CPEB2","translation","angiogenesis","hypoxic stress response","Cell Biology","Molecular Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/9182"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Chronic pulmonary hypoxia commonly results in the sustained expression of HIF1 (hypoxia inducible factor 1), a heterodimeric transcription factor, that, if unrestrained, can result in dramatic vasculature remodeling, pulmonary arterial hypertension, and right-sided heart failure. Together, these pulmonary disorders cost approximately $100 billion annually to treat due to the limited therapeutic targets designed to inhibit HIF1 expression. In this study, we introduce a translational regulator of HIF1 expression, known as Cytosolic polyadenylation element binding proteins 2 (CPEB2). Our lab has previously demonstrated in cancer cells that alternatively spliced isoforms of CPEB2 regulate the translation of the HIF1 oxygen-dependent subunit, HIF1α, in opposing fashions: the CPEB2A isoform represses its translation, while the CPEB2B isoform activates its translation. Although it is well established that during hypoxia, HIF1α levels are initially upregulated due to a decrease in proteasomal degradation, we hypothesized that during prolonged, or chronic, hypoxia, the expression of HIF1α is maintained through a stress-induced translational mechanism, likely alongside a decrease in proteolytic activity meant to stabilize HIF1α protein. Here we have demonstrated that targeting the CPEB2B splice isoform inhibited the translation of nascent HIF1α protein during chronic hypoxia, but not during acute hypoxia exposure. Moreover, we characterized how CPEB2A and B expression impacts vasculature remodeling in a 3D angiogenic cell model. These findings provide evidence that this splicing event could act as a therapeutic target for treating chronic hypoxia-related pulmonary diseases and diseases that present with dysregulated HIF1 expression."]},{"key":"dc:title","label":"Title","values":["Cytoplasmic Polyadenylation Element Binding Protein 2 Alternative Splicing Regulates HIF1α During Chronic Hypoxia"]}]}],"canonical_facts":{"dc:contributor":["Sandy Westerheide, Ph.D.","Margaret Park, Ph.D., M.S.","Marcus Cooke, Ph.D."],"dc:creator":["Mayo, Emily M."],"dc:date":["2021-06-24T07:00:00Z"],"dc:description":["Chronic pulmonary hypoxia commonly results in the sustained expression of HIF1 (hypoxia inducible factor 1), a heterodimeric transcription factor, that, if unrestrained, can result in dramatic vasculature remodeling, pulmonary arterial hypertension, and right-sided heart failure. Together, these pulmonary disorders cost approximately $100 billion annually to treat due to the limited therapeutic targets designed to inhibit HIF1 expression. In this study, we introduce a translational regulator of HIF1 expression, known as Cytosolic polyadenylation element binding proteins 2 (CPEB2). Our lab has previously demonstrated in cancer cells that alternatively spliced isoforms of CPEB2 regulate the translation of the HIF1 oxygen-dependent subunit, HIF1α, in opposing fashions: the CPEB2A isoform represses its translation, while the CPEB2B isoform activates its translation. Although it is well established that during hypoxia, HIF1α levels are initially upregulated due to a decrease in proteasomal degradation, we hypothesized that during prolonged, or chronic, hypoxia, the expression of HIF1α is maintained through a stress-induced translational mechanism, likely alongside a decrease in proteolytic activity meant to stabilize HIF1α protein. Here we have demonstrated that targeting the CPEB2B splice isoform inhibited the translation of nascent HIF1α protein during chronic hypoxia, but not during acute hypoxia exposure. Moreover, we characterized how CPEB2A and B expression impacts vasculature remodeling in a 3D angiogenic cell model. These findings provide evidence that this splicing event could act as a therapeutic target for treating chronic hypoxia-related pulmonary diseases and diseases that present with dysregulated HIF1 expression."],"dc:identifier":["https://digitalcommons.usf.edu/etd/9182"],"dc:subject":["CPEB2","translation","angiogenesis","hypoxic stress response","Cell Biology","Molecular Biology"],"dc:title":["Cytoplasmic Polyadenylation Element Binding Protein 2 Alternative Splicing Regulates HIF1α During Chronic Hypoxia"],"thesis:degree_discipline":["Biology (Cell Biology, Microbiology, Molecular Biology)"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:47:49Z"}